Author: Michelle Gischewski, Scientific Advisor, Drug Product Operations at Eurofins CDMO Alphora Inc.
Targeted bioavailability enhancement strategies can help improve the success of early drug candidates by maximizing the API’s exposure in early in-vivo studies. This whitepaper discusses commonly used technologies & supporting services that can help enhance bioavailability of poorly soluble compounds.
